Atara Biotherapeutics (ATRA) Tax Provisions (2013 - 2025)
Atara Biotherapeutics (ATRA) posted Tax Provisions of $28000.0 for Q3 2025, up 833.33% on a QoQ basis from $3000.0 in Q2 2025, and up 264.71% year-over-year from $7677.4 in Q3 2024.
Atara Biotherapeutics (ATRA) Tax Provisions (2013 - 2025) Analysis & Trends
Atara Biotherapeutics' Tax Provisions history runs 13 years deep, the most recent figure standing at $28000.0 for Q3 2025.
- Quarterly Tax Provisions rose 264.71% year-over-year to $28000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $31000.0 (up 186.11% YoY) and the FY2025 annual result came in at $31000.0, up 358.33% from the prior year.
- Tax Provisions was $28000.0 for Q3 2025 at Atara Biotherapeutics, up from $3000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $30000.0 in Q4 2021 and bottomed at -$19000.0 in Q3 2023.
- A 5-year average of $7076.9 and a median of $10000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2021 — Tax Provisions jumped 1500.0% — and 2023, when it plunged 290.0%.
- Atara Biotherapeutics' Tax Provisions stood at $30000.0 in 2021, then slumped by 93.33% to $2000.0 in 2022, then surged by 450.0% to $11000.0 in 2023, then sank by 272.73% to -$19000.0 in 2024, then jumped by 247.37% to $28000.0 in 2025.
- Business Quant data shows ATRA's Tax Provisions at $28000.0 in Q3 2025, $3000.0 in Q2 2025, and -$19000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Dec 31, 2024 | -19,000.00 |
| Sep 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | -19,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Dec 31, 2020 | 8,000.00 |
| Sep 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Dec 31, 2019 | 12,000.00 |
| Dec 31, 2018 | -47,000.00 |
| Jun 30, 2018 | 3,000.00 |
| Dec 31, 2017 | -16,000.00 |